Innovation begins not with complexity, but with curiosity — a simple question that demands a better answer. At Murli Krishna Pharma (MKPPL), our journey into liposomal technology
Murli Krishna Pharma is redefining the way the world experiences health, wellness, and beauty through its cutting-edge liposomal nano-encapsulation technology. With a commitment to innovation, quality, and
Strong leadership shapes the pharmaceutical industry’s future, driving innovation that saves millions of lives worldwide. Dr. Satya Vadlamani, Managing Director of Murli Krishna Pharma Pvt. Ltd. (MKPPL),
The pharmaceutical industry relies on connections, partnerships, and shared innovation to bring life-saving medicines to patients worldwide. CPhI (Convention on Pharmaceutical Ingredients) stands as the most important
The global pharmaceutical industry is seeing tremendous changes in 2025, highlighted by advancements set to be presented at CPhI Frankfurt (Oct 28-30), and the innovative vision of
Sita Mahalakshmi Challa, mother of Dr. Satya Ramani Vadlamani, was more than a pioneering leader in the pharmaceutical world—she was a beacon of strength, love, and wisdom.
African’s healthcare system is faced with persistent challenges, namely, underfunding, limited access to essential services, and the growing burden of diseases especially Anemia. Despite these obstacles, Africa
Murli Krishna Pharma Pvt. Ltd., under the visionary leadership of Dr. Satya Vadlamani, is delighted to announce its strategic entry into the African Market. This milestone marks
April, 2025 – Murli Krishna Pharma Pvt. Ltd., under the visionary leadership of Dr. Satya Vadlamani, is set to transform healthcare in Africa with its innovative solutions addressing